Add Formweb to your mobile device
System Formulary Update
Melphalan Flufenamide (Pepaxto) Removal
Situation
Per the December UNC Health System P&T meeting, we will be removing melphalan flufenamide (Pepaxto) injection from the UNC Health System Medication formulary.
Background
In October 2021, melphalan flufenamide (Pepaxto) was voluntarily withdrawn from the US market by the manufacturer. The manufacturer will work with the FDA to continue to make melphalan flufenamide (Pepaxto) available to existing patients who were receiving benefit from therapy. Information can be found on Oncopeptides, Inc. website at the following link: Oncopeptides, Inc. Patient Assistance Program
Assessment/Recommendation
Go-Live: Tuesday, February 1st
|
Excluded from UNC Health System Drug Formulary |
|
• Melphalan Flufenamide 20 mg Intravenous Solution [191127] |